HFE Gene Mutations and Neurodegenerative Diseases
Author Information
Author(s): Rita J Guerreiro, Jose M Bras, Isabel Santana, Cristina Januario, Beatriz Santiago, Ana S Morgadinho, Maria H Ribeiro, John Hardy, Andrew Singleton, Catarina Oliveira
Primary Institution: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, USA
Hypothesis
Are HFE mutations associated with Parkinson's disease, Alzheimer's disease, and mild cognitive impairment in a Portuguese cohort?
Conclusion
The common variants in HFE may be a risk factor for Parkinson's disease, but not for Alzheimer's disease in the Portuguese population.
Supporting Evidence
- A significant association was found in the Parkinson's disease group compared to controls.
- The presence of the C282Y variant allele may confer a higher risk for developing Parkinson's disease.
- No significant differences were found in the Alzheimer's disease or mild cognitive impairment groups compared to controls.
Takeaway
This study looked at whether certain gene changes are linked to brain diseases like Parkinson's and Alzheimer's. They found that one gene change might increase the risk of Parkinson's but not Alzheimer's.
Methodology
Genotypes were analyzed for the two most common variants of HFE in patients with Alzheimer's disease, mild cognitive impairment, and Parkinson's disease, compared to healthy controls.
Potential Biases
Potential for false positive findings due to small sample sizes and population differences.
Limitations
The small sample size limits the statistical power of the analysis.
Participant Demographics
Participants were Caucasian with apparent Portuguese ancestry, including 130 Alzheimer's patients, 55 mild cognitive impairment patients, and 132 Parkinson's patients.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website